2005
DOI: 10.1016/j.molbrainres.2005.01.015
|View full text |Cite
|
Sign up to set email alerts
|

Localization of kainate receptor subunit GluR5-immunoreactive cells in the rat hypothalamus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
11
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 34 publications
4
11
0
1
Order By: Relevance
“…Thus, kainic acid receptors likely are the predominant subclass of glutamate receptors in the VMH that stimulate the counterregulatory responses. This finding is consistent with previous reports that showed that activation of VMH kainic acid receptors enhances sympathetic drive to endocrine and neuroendocrine systems, helping to raise plasma glucose concentrations (13,2629). Although the agonists used in the current study are selective for their respective targets, some overlap exists in the selectivity of the AMPA and kainic acid receptor antagonists.…”
Section: Discussionsupporting
confidence: 93%
“…Thus, kainic acid receptors likely are the predominant subclass of glutamate receptors in the VMH that stimulate the counterregulatory responses. This finding is consistent with previous reports that showed that activation of VMH kainic acid receptors enhances sympathetic drive to endocrine and neuroendocrine systems, helping to raise plasma glucose concentrations (13,2629). Although the agonists used in the current study are selective for their respective targets, some overlap exists in the selectivity of the AMPA and kainic acid receptor antagonists.…”
Section: Discussionsupporting
confidence: 93%
“…Anatomical evidence suggests that receptors from the n-methyl-d-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate receptor families, as well as metabotropic receptors, are localized in CRH-containing regions of the PVN (Herman et al, 2000; Scaccianoce et al, 2003; Eyigor et al, 2005; Ziegler et al, 2005). Antagonist studies have demonstrated functional roles for ionotropic (Ziegler and Herman, 2000) and metabotropic (Johnson et al, 2001; Scaccianoce et al, 2003) glutamate receptors in regulation of the HPA axis.…”
Section: Introductionmentioning
confidence: 99%
“…Early ultrastructural evidence confirmed glutamate immunopositive synaptic vesicles at asymmetric synapses within the PVH (Bartanusz et al, 2004; Decavel and Van den Pol, 1992; Van den Pol, 1990, 1991), suggesting that glutamate may account for as much as 50% of all synapses within the nucleus (Van den Pol, 1991). This report was followed by studies showing glutamate receptor binding and mRNA and protein expression for glutamate receptor subunits in the PVH (Al-Ghoul et al, 1997; Aubry et al, 1996; Eyigor et al, 2001, 2005; Herman et al, 2000; Khan et al, 2000; Kiss et al, 1996; Mateos et al, 1998; Oliver et al, 1996; Petralia and Wenthold, 1996; Sato et al, 1993; Tasker et al, 1998; Van den Pol et al, 1994; Ziegler et al, 2005). In addition to these anatomical data, electrophysiological data from cultured slices have documented functional excitatory responses of PVH neurons to glutamatergic input (Bartanusz et al, 2004; Boudaba et al, 1997; Daftary et al, 1998, 2000; Van den Pol et al, 1990, 1996; Wuarin and Dudek, 1991) and in vivo studies involving glutamate or glutamate receptor antagonist microinjections in the PVH led to stimulation/inhibition of the HPA axis at the level of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and corticosterone secretion (Cole and Sawchenko, 2002).…”
mentioning
confidence: 96%